Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Med Mycol. 2021 Nov 3;59(11):1092-1100. doi: 10.1093/mmy/myab044.
Invasive fungal infections pose a severe threat in unconventional immunocompromised hosts such as cirrhosis. Herein we review the impact of invasive aspergillosis (IA) on the prognosis of cirrhosis patients. An electronic search for full-text articles describing IA in cirrhosis was conducted and the disease outcomes and mortality (point-estimate and comparative risk) were pooled on random-effects meta-analysis. Of 4127 articles, 11 studies (9 with good/fair and 2 with poor quality) were included. IA was associated with high disease severity and multi-organ failures in cirrhosis. The pooled-mortality of IA was 81.8% (95% CI: 64.3-91.8, I2 = 59%, P < 0.01). Estimate's-heterogeneity (I2) was explored through sub-groups, meta-regression, and influential diagnostics. Mortality estimates were higher among subgroups of acute-on-chronic liver failure (ACLF, 86.4%) and intensive care unit (ICU)-admitted patients (84.0%). The odds of mortality related to IA were 8.9 times higher than controls and much higher in ACLF (OR: 22.5) and ICU-admitted patients (OR: 36.4). The odds of mortality in IA were 4.1, 12.9, and 48.6 times higher than bacterial, no-fungal infections, and no-infection controls. There was no asymmetry in mortality estimates or odds ratios and mortality in IA was high irrespective of country of origin, site of infection, proven or probable category, and quality of study. Thus, IA is associated with very high mortality in cirrhosis patients, especially in ACLF and ICU-admitted patients. Intensive research is needed for the rapid diagnosis and treatment of IA in cirrhosis.
We report a high mortality rate of 81.8% in patients with liver cirrhosis and invasive aspergillosis. Higher odds (8.9 times) of death, especially in patients with ACLF or ICU admission were seen. Mortality was not affected by the country of study, site of infection, proven or probable nature of infection category, and quality of study.
探讨侵袭性曲霉菌感染(IA)对肝硬化患者预后的影响。
我们对描述肝硬化合并曲霉菌感染的全文文章进行了电子检索,并采用随机效应荟萃分析对疾病结局和死亡率(点估计和比较风险)进行了汇总。
在 4127 篇文章中,纳入了 11 项研究(9 项为质量较好/中等,2 项为质量较差)。IA 与肝硬化患者的疾病严重程度和多器官衰竭有关。IA 的汇总死亡率为 81.8%(95%CI:64.3-91.8,I2=59%,P<0.01)。通过亚组、meta 回归和有影响力的诊断方法探讨了异质性(I2)的估计。在慢性肝衰竭(ACLF)和入住重症监护病房(ICU)的亚组中,死亡率较高(ACLF:86.4%,ICU 入住:84.0%)。IA 相关死亡率的比值比(OR)为 8.9 倍,ACLF 患者(OR:22.5)和 ICU 入住患者(OR:36.4)更高。IA 相关死亡率分别比细菌感染、无真菌感染和无感染对照高 4.1、12.9 和 48.6 倍。死亡率估计值或比值比没有不对称性,IA 患者的死亡率较高,而不论其原籍国、感染部位、确诊或疑似感染类别以及研究质量如何。
IA 与肝硬化患者的死亡率密切相关,尤其是在 ACLF 和 ICU 入住患者中。需要进行深入研究,以快速诊断和治疗肝硬化患者的 IA。